Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.

MLA

Vyas, Avani, et al. “Lysosomal Inhibition Sensitizes TMEM16A-Expressing Cancer Cells to Chemotherapy.” Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 12, Mar. 2022, p. e2100670119. EBSCOhost, https://doi.org/10.1073/pnas.2100670119.

APA

Vyas, A., Gomez-Casal, R., Cruz-Rangel, S., Villanueva, H., Sikora, A. G., Rajagopalan, P., Basu, D., Pacheco, J., Hammond, G. R. V., Kiselyov, K., & Duvvuri, U. (2022). Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy. Proceedings of the National Academy of Sciences of the United States of America, 119(12), e2100670119. https://doi.org/10.1073/pnas.2100670119

Chicago

Vyas, Avani, Roberto Gomez-Casal, Silvia Cruz-Rangel, Hugo Villanueva, Andrew G Sikora, Pavithra Rajagopalan, Devraj Basu, et al. 2022. “Lysosomal Inhibition Sensitizes TMEM16A-Expressing Cancer Cells to Chemotherapy.” Proceedings of the National Academy of Sciences of the United States of America 119 (12): e2100670119. doi:10.1073/pnas.2100670119.